Researchers Highlight the Best Time for RSV Vaccine During Pregnancy Dr. Bhumika Maikhuri13 Nov 2024 8:30 AM ISTCurrent guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-which typically causes mild, cold-like...
Approximately 80 Percent Protection May be Provided by RSV Vaccine Against Severe Disease and Death: Study Suggests Dr. Bhumika Maikhuri21 Oct 2024 8:15 AM ISTA multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the respiratory syncytial virus...
Hospitalized patients with RSV infections are at higher risk of mortality, finds study Jacinthlyn Sylvia21 Oct 2024 8:00 AM ISTA new study published in the journal of Open Forum Infectious Diseases showed that older adults hospitalized with respiratory syncytial virus (RSV)...
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Medical Bulletin 15/ October/ 2024 Dr. Bhumika Maikhuri15 Oct 2024 3:00 PM ISTHere are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 American adults commissioned...
Study Identifies Signs Tied to More Severe Cases of RSV Dr. Bhumika Maikhuri15 Oct 2024 8:15 AM ISTRespiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis and...
Ziresovir Shows Promise in Alleviating Bronchiolitis Symptoms in Hospitalized Infants with RSV: Study Medha Baranwal28 Sept 2024 12:45 AM ISTChina: In a promising development for pediatric care, a recent study has highlighted the efficacy of Ziresovir in treating infants hospitalized due to...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal for antimicrobial drug Sisunatovir study Dr. Divya Colin9 Sept 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
New RSV vaccine can result in individual and societal cost savings, benefits for elderly: Study Dr. Kamal Kant Kohli6 Sept 2024 8:30 PM ISTVaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of...
Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
New JAMA study backs RSV vaccine safety during pregnancy Dr. Kamal Kant Kohli10 July 2024 4:00 AM ISTVaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk...
